Analysis of an additional dataset, the REpository for Molecular BRAin Neoplasia DaTa (REMBRANDT) [29], showed that increased expression of HK2 was associated with overall poorer survival in GBM patients (Supplementary Figure S1F, *p = 0.05). This evidence concerns the gene HK2 and glioblastoma.